HLA-B*3531, a hybrid of B35 and B61, implications for diagnostic approaches to alleles with complex ancestral compositions.
The serological characterization of allelic variants that have been generated by large-scale interallelic recombination events indicates which residues may be involved in the formation of epitopes crucial for serological recognition. The allelic product of HLA-B*3531 is composed of B35 in its alpha1 domain and of B61(40) in its alpha2 domain. Both specificities are only weakly detectable with available sera. Allelic products with 'mixed' serology also represent a challenge to DNA-based HLA typing methods, as only the sequence motif of one ancestral allele may be recognized. In this case the hidden specificity would not be considered in the matching process and might not be recognized as an antigen 'unacceptable' to the recipient.
D000483:Alleles; D000595:Amino Acid Sequence; D001482:Base Composition / Q000235:genetics*; D001483:Base Sequence; D002678:Chimera / Q000235:genetics*; D005819:Genetic Markers / Q000235:genetics; D015235:HLA-B Antigens / Q000235:genetics*; D015797:HLA-B35 Antigen / Q000235:genetics*; D006650:Histocompatibility Testing; D006801:Humans; D008969:Molecular Sequence Data; D011110:Polymorphism, Genetic / Q000235:genetics; D012680:Sensitivity and Specificity
D005819:Genetic Markers; D015235:HLA-B Antigens; D015797:HLA-B35 Antigen; C079077:HLA-B61 antigen